Accumulating evidence has shown that PCNA-AS1 is overexpressed in non-small cell lung cancer [17], CRC [18], gastric cancer [19] and hepatocellular carcinoma [20]. This evidence concerns the gene PCNA and hepatocellular carcinoma.